What is Sutro Biopharma's EV / sales?

Sutro Biopharma (STRO) reported EV / sales of 3.5× in Q1 2026.

How has Sutro Biopharma's EV / sales changed year-over-year?

Sutro Biopharma's EV / sales increased by 875.5% year-over-year, from -0.5× to 3.5×.

What is the long-term trend for Sutro Biopharma's EV / sales?

Over 5 years (2020 to 2025), Sutro Biopharma's EV / sales has grown at a -51.3% compound annual growth rate (CAGR), from 20× to 0.5×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Sutro Biopharma STRO EV / sales

EV / sales at other companies

PfizerPFE

3.5×+0.3×

Gilead SciencesGILD

6.3×+0.9×

RegenxbioRGNX

5.6×+3.6×

XencorXNCR

10.7×+3.4×

AnaptysBio, Inc.ANAB

5.8×+1.4×

SchrodingerSDGR

2.7×-2.6×

Other financials

Income statement

See full

Revenue$14.5M-16.5%

Operating income-$29.7M+56.7%

Net income-$38.5M+49.3%

EPS (diluted)-$2.94+67.6%

Balance sheet

See full

Cash & equivalents$73.7M-30.6%

Total debt$13.6M-36.3%

Total equity-$66.9M-159%

Total assets$242.0M-24.7%

Cash flow

See full

Operating cash flow-$42.3M+37.7%

CapEx--100%

Free cash flow-$42.3M+37.8%

Valuation

See full

Market cap$489.66M+624%

Enterprise value$429.61M-2,600%

P/S4.9×+3.9×

Profitability

See full

Operating margin-120%-48.6pp

Net margin-154.2%-56.7pp

FCF margin-152.2%-51.1pp

Returns & leverage

See full

Return on equity-234.2%—

Debt / equity0.5×+0.3×

Current ratio3.1×+1.0×

Where this comes from

Calculated from Sutro Biopharma’s reported figures.

enterprise value/total revenue=3.5×

Based on the most recent quarter.

The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sutro Biopharma's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Sutro Biopharma's EV / sales?: Sutro Biopharma (STRO) reported EV / sales of 3.5× in Q1 2026.
How has Sutro Biopharma's EV / sales changed year-over-year?: Sutro Biopharma's EV / sales increased by 875.5% year-over-year, from -0.5× to 3.5×.
What is the long-term trend for Sutro Biopharma's EV / sales?: Over 5 years (2020 to 2025), Sutro Biopharma's EV / sales has grown at a -51.3% compound annual growth rate (CAGR), from 20× to 0.5×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.